Skip to main content

Advertisement

Figure 1 | Clinical Epigenetics

Figure 1

From: Polycomb-mediated silencing in neuroendocrine prostate cancer

Figure 1

Differential expression of epigenetic regulators in NEPC. Average fold change of individual EpRs grouped by distinct (A) epigenetic modifications, (B) epigenetic activities, and (C) transcriptional effects in clinical NEPC/PCa and the 331R/331 model. (D) Expression correlation of 22 EpRs upregulated by more than 1.5-fold in clinical NEPC/PCa and the 331R/331 model. (E) Expression levels of individual upregulated EpRs in clinical NEPC/PCa and the 331R/331 model.

Back to article page